RDHL - Latest News
RedHill Biopharma Ltd. (RDHL), operates in Healthcare / Drug Manufacturers - Specialty & Generic, trades on NASDAQ.
Market capitalization stands near $2.1M. Beta to the broader market is 4.90.
The article list below shows the most recent RDHL headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent RDHL Headlines
RedHill Divests Talicia® to Apotex for $18 Million Cash Upfront Plus Milestones to Fuel Strategic Growth Opportunities
prnewswire.com - Aug 31, 2026
Executes a major step in RedHill's strategic roadmap to fundamentally reposition the Company's commercial business toward new and larger product oppor
Ebola Cases and Deaths Rapidly Mount - RedHill Updates on Opaganib Emergency Outbreak Development
prnewswire.com - Jul 28, 2026
The number of confirmed Ebola cases and deaths has increased substantially to 3221 cases and 1407 deaths -- Finalization of development next steps and
RedHill Biopharma Announces Closing of Up To $19.4 Million Private Placement
prnewswire.com - Jun 22, 2026
$6 million upfront with up to approximately $13. 4 million of potential aggregate gross proceeds upon the exercise in full of warrants TEL AVIV, Israe
RedHill Biopharma Announces Up To $19.4 Million Private Placement
prnewswire.com - Jun 18, 2026
$6 million upfront with up to approximately $13. 4 million of potential aggregate gross proceeds upon the exercise in full of warrants TEL AVIV, Israe
RedHill's Opaganib Receives FDA Rare Pediatric Disease Designation for Neuroblastoma in Addition to Current Orphan Drug Designation
prnewswire.com - Jun 9, 2026
The U. S.
How News Affects RDHL Options Pricing
Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track RDHL's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.
Frequently asked RDHL news questions
- What is the latest RDHL news headline?
- The most recent RDHL headline (Aug 31, 2026) is "RedHill Divests Talicia® to Apotex for $18 Million Cash Upfront Plus Milestones to Fuel Strategic Growth Opportunities". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the RDHL news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What RDHL news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual RDHL options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.